AGM/EGMJul 31, 2026, 07:51 AM
Virax Biolabs to Vote on Share Capital Increase at EGM
AI Summary
Virax Biolabs Group Ltd announced an Extraordinary General Meeting (EGM) to be held on August 14, 2026. Shareholders will vote on a proposal to significantly increase the company's authorized share capital from US$50,000 to US$12,500,000, by creating 498,000,000 new ordinary shares. This increase is intended to support the company's basic financing needs and potential business development transactions. Additionally, shareholders will consider adopting an amended charter to reflect this capital increase. The Board of Directors unanimously recommends that shareholders vote in favor of all proposals.
Key Highlights
- Extraordinary General Meeting (EGM) scheduled for August 14, 2026, at 2:00 p.m. local time.
- Proposal to increase authorized share capital from US$50,000 to US$12,500,000.
- This involves creating 498,000,000 new ordinary shares of US$0.025 par value each.
- The capital increase is for basic financing needs and potential business development transactions.
- Shareholders will vote on adopting a fifth amended and restated memorandum and articles of association.
- The Board of Directors unanimously recommends voting "FOR" all proposals.
- Record date for voting eligibility is July 27, 2026.
Price Impact
More from VRAX